Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Postmenopausal bleeding (author's transl)]

S Samartzis, G A Hauser

    Geburtshilfe Und Frauenheilkunde
    |April 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Postmenopausal bleeding is often caused by genital carcinoma, endometrial atrophy, or uterine polyps. A significant delay exists between symptom onset and diagnosis, particularly for corpus carcinoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [The Menopause Rating Scale (MRS II): methodological standardization in the German population].

    Zentralblatt fur Gynakologie·2000
    Same author

    [Evaluation of hormone replacement therapy in the perimenopause by means of Menopause Rating Scale (MRS I)].

    Zentralblatt fur Gynakologie·1999
    Same author

    [A new rating scale for the climacteric syndrome (Menopause Rating Scale (MRS)].

    Schweizerische medizinische Wochenschrift·1997
    Same author

    [Diagnosis and evaluation of climacteric symptoms. The "Menopause Rating Scale" MRS helps in diagnosis and evaluation of therapeutic effectiveness].

    Fortschritte der Medizin·1996
    Same author

    [Evaluation of climacteric symptoms (Menopause Rating Scale)].

    Zentralblatt fur Gynakologie·1994
    Same author

    [Hormone substitution in the female climacteric--goals, means, effects].

    Therapeutische Umschau. Revue therapeutique·1990
    Same journal

    Consensus on the Management of Inavolisib Side Effects. A Survey on Defined Side Effects, the Assumed Pathomechanism, Preventative and/or Therapeutic Measures Including the Integration of Additional Health Care Professionals - a Consensus Paper.

    Geburtshilfe und Frauenheilkunde·2026
    Same journal

    Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025.

    Geburtshilfe und Frauenheilkunde·2026
    Same journal

    Feasibility of <i>PIK3CA</i> Mutation Detection via Microfluidic Isolation of Disseminated Tumor Cells from Bone Marrow in Breast Cancer Patients.

    Geburtshilfe und Frauenheilkunde·2026
    Same journal

    Stereotactic Vacuum-Assisted Biopsy in Photon-Counting Dedicated Spiral Breast CT: A Proof of Concept.

    Geburtshilfe und Frauenheilkunde·2026
    Same journal

    RSV Prophylaxis in Neonates: Implementation and Parental Acceptance during the First RSV Season in Germany.

    Geburtshilfe und Frauenheilkunde·2026
    Same journal

    Genital Herpes Simplex Virus (HSV) Infection During Pregnancy - Recommendations of the Working Group on Obstetrics and Prenatal Medicine (AGG - Section on Maternal Disorders).

    Geburtshilfe und Frauenheilkunde·2026
    See all related articles

    Area of Science:

    • Gynecology
    • Oncology

    Context:

    • Analysis of 554 postmenopausal bleeding cases over 11 years (1961-1971).
    • Postmenopausal bleeding constitutes 4.1% of gynecological admissions.

    Purpose:

    • To investigate the causes of postmenopausal bleeding.
    • To analyze the delay in diagnosis for gynecological malignancies.

    Summary:

    • Genital carcinoma caused 35.3% of cases; endometrial atrophy (28.5%) and uterine polyposis (21.2%) were leading nonmalignant causes.
    • Corpus carcinoma (51%) and cervical cancer (38%) were the most frequent malignancies.
    • Average diagnostic delay was 19.2 weeks, significantly longer for corpus carcinoma (36.3 weeks).

    Impact:

    • Highlights the prevalence of malignancy in postmenopausal bleeding.

    Related Experiment Videos

  • Underscores the critical need for timely diagnosis to improve patient outcomes.
  • Provides historical data on diagnostic timelines in gynecological oncology.